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Abstract 
Background: Brown adipose tissue (BAT) uncouples respiration, using lipids as an energy 
source while dissipating heat. Increases in BAT activity are protective against obesity, thus 
compounds that increase BAT activation may help prevent weight gain. Resveratrol (R) increases 
BAT activity by upregulating thermogenic genes. As phytochemicals have synergistic properties, 
our research strategy has included investigation of the efficacy of relatively low concentrations of 
phytochemical blends on BAT activation. 
 
Methods: Previously, we showed that R combined with genistein (G) and quercetin (Q) reduced 
weight gain in aged ovariectomized (OVX) female rats. In the current study, OVX rats were fed 
diets containing doses of phytochemicals with vitamin D (diet 1: 1000 mg/kg G; diet 2: 500 mg/kg 
G, 200 mg/kg R, and 1000 mg/kg Q; diet 3: 1000 mg/kg G, 400 mg/kg R, and 2000 mg/kg Q). 
 
Results: After 16 weeks, rats in the high dose group had a significantly smaller scapular BAT 
depot compared to non-OVX controls (0.74 g v 0.92 g; p<0.05). It was hypothesized that the 
reduction in BAT mass was due to phytochemical-driven increases in BAT lipid metabolism. After 
16-weeks reduced lipid content in BAT of the high dose group was seen compared to non-OVX 
controls (0.35 ± 0.02 v 0.44 ± 0.04; p=0.01). Two-fold increases in BAT-related genes including 
Sirt3, Nrf1, and Pparg1c were observed in the high dose group compared to non-OVX controls 
(p<0.10). Similarly, Acc1 expression was increased by 34-fold (p<0.02) and Lipe expression was 
increased by 29-fold (p<0.004) in the high dose group. 
 
Conclusions: These findings are consistent with our hypothesis that a dietary phytochemical 
blend increases energy utilization and respiration in BAT. These data provide further support for 
the anti-obesity effects of synergistic phytochemical combinations. 
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-Fischer 344 female rats (retired breeders, n=34) were obtained from the NIA colony from Tacona. 
They were adapted to a basal maintenance diet (a semipurified phytoestrogen-free casein-based 
diet, AIN-93M in a meal form with 4% safflower oil) for one week upon arrival. Rats were either 
ovariectomized or given sham surgery 1 week prior to being fed food containing test compounds 
for 16 weeks. Food intake was measured on a daily basis and body weights were monitored 
weekly. 
-Upon sacrifice, adipose tissues were dissected and frozen in liquid nitrogen. mRNA was obtained 
using Trizol  Reagent and converted to cDNA using Reverse Transcription kit by Applied 
Biosystems. Quantitative PCR was performed for adipose-related genes with primers from Applied 
Biosystems using the 7500 system. 
-Total protein was extracted using modified RIPA buffer containing a protease inhibitor cocktail 
from Sigma-Aldrich. Protein concentrations were measured using the Bradford Assay Reagent 
(Sigma).  
-Lipids were extracted using the Folch method, and the concentration was determined and 
normalized to protein extraction data. 
-Statistics were performed using one-way ANOVA and Fisher LSD post-hoc testing. Significance 
was set at p<0.05. 
 
 
 
  
 
 
Diet 
Non-OVX or 
OVX 
Treatment VD (IU/Kg 
diet) 
2,5 –OH  D3 
G (mg /Kg 
diet) 
Genistein  
aglycone 
R (mg/Kg 
diet)  
Trans - 
Resveratrol 
Q (mg/Kg 
diet) 
Quercetin 
hydrate 
Non-OVX Control 1000 0 0 0 
OVX Control 1000 0 0 0 
OVX VD/G 2400 1000 0 0 
OVX VD/R/Q/G 
(1) 
2400 500 200 1000 
OVX VD/R/Q/G 
(2) 
2400 1000 400 2000 
 
 
 
  
 
 
Body Weight Change  
 
 
  
 
 
BAT Tissue Weight 
 
 
 
  
 
 
BAT-Related Genes 
 
 
 
  
 
 
Lipogenic Genes 
 
 
 
  
 
 
Lipolytic Genes 
 
 
 
  
 
 
Lipid Concentration 
Mitochondrial Protein 
Phytochemical Synergy 
 
 
 
  
 
 
Conclusions 
Ovariectomy results in a rapid increase in weight gain and adiposity as a direct result of the loss of 
17β-estradiol, the major circulating sex hormone in females. A plethora of research exists on the 
many mechanisms behind ovariectomy-induced weight gain, however the impact of the loss of 
estradiol on BAT function is deficient. It has been previously suggested that females have more 
active BAT stores than males (Cell Physiol Biochem 2007;19:195-204). Unfortunately the affects of 
ovariectomy on BAT have not been as equally addressed in the literature. Early studies have not 
identified that a loss of BAT is a major contributing factor to ovariectomy-induced weight gain (Am 
J Physiol 1986;250:R245-249). Despite the limited research in BAT, increases in adiposity caused 
by deficiencies in estradiol result in an increased risk for the development of metabolic diseases 
(Cardiovas Endorinol 2003; 88:2404). Activation of BAT in menopausal females and rodent models 
of menopause may prove to be a novel way to prevent shifts in fat distribution and gains in total 
adiposity when estradiol is lost. 
 
Cold activation of BAT has proven to be extremely effective in promoting fat oxidation and weight 
loss. Activated BAT can burn up to 250 kcal every 3 hours, increasing metabolic rate by 80% (J 
Clin Invest 2012;22:545-552). While very potent, problems arise with using cold temperatures as a 
therapeutic agent. In addition to difficulties in maintaining protocol compliance, exposure to cold 
results in increased appetite (J Comp Physiol Psychol 1979;93:1024-1034). Furthermore, cold 
temperatures may also increase the risk of sudden cardiac death (Cell Metab 2013;18:118-129). 
For these reasons, pharmaceutical agents can provide a simiplier method of activating BAT and 
with possibly increased safety. 
 
Phytochemicals have been identified  in the literature to exert effects on BAT functioning. One such 
example is the nutraceutical compound resveratrol, which is found readily in grapes and their 
products. Resveratrol has shown to increase mitochondrial biogenesis through enhancing PGC1α 
and SIRT1 activity (Cell 2006;127:1109-1122). Both of these proteins have been identified as 
major drivers in both maintaining and inducing brown fat activity (Am J Clin Nutr 2011; 93:884S-
890). Furthermore resveratrol also appears to induce UCP1 gene expression in ob/ob mice 
(FASEB J;23:1032-1040). While resveratrol  has shown promise in cell and animal work in helping 
prevent or alleviate disease progression, resveratrol is not practical for pharmaceutical use in 
humans. Based off of some animal studies, doses of upwards of 28 g/d of resveratrol 
supplementation would be required to exert similar affects in humans (Mol Nutr Food Res 
2011;55:1177-1185). Fortunately, recent  studies have shown that phytochemicals including 
resveratrol have synergistic properties. Therefore, the role of synergistic blends of phytochemicals 
needs to be investigated as a way to manage adiposity and prevent obesity. 
Phytochemicals have multiple targets on genes related to thermogenesis. 
Taking advantage of such synergy reduces the doses required for activating BAT to 
levels that can be easily ingested in humans. Upregulation of thermogenic genes by 
phytochemical combinations also is independent of sympathetic nervous system 
stimulation, and thus is suggested to be safer than pharmaceutical/cold stimulation.  
Summary 
• Ovariectomy did not significantly reduce scapular BAT weight, 
however high dose phytochemical treatment resulted in a loss of 
BAT weight. This loss of BAT tissue is presumably due to a 
reduced lipid concentration as no difference was found in 
mitochondrial protein content. 
 
• While UCP1 was not significantly upregulated, genes that 
regulate UCP1 (SIRT3) was significantly increased with 
treatment. Furthermore genes related to mitochondrial 
biogenesis (NRF1 & PGC1α) was also upregulated. 
 
• Genes related to lipid synthesis (ACC1 & FAS) and 
mobilization (HSL & ATGL) was upregulated with phytochemical 
treatment in a dose-dependent response.   
While our high dose phytochemical blend resulted in a loss of 
scapular BAT, the reduced lipid concentration along with 
upregulated thermogenic, lipogenic, and lipolytic gene 
expression indicates a more active tissue. 
